Key result
Non-alcoholic fatty liver disease was independently associated with a higher prevalence of metabolic syndrome and more severe metabolic disorders in patients with latent autoimmune diabetes.
Why the study?
Is the presence of non-alcoholic fatty liver disease associated with a higher prevalence of metabolic syndrome in patients with latent autoimmune diabetes in adults?
Is the presence of non-alcoholic fatty liver disease associated with a higher prevalence of metabolic syndrome in patients with latent autoimmune diabetes in adults?
Non-alcoholic fatty liver disease is independently associated with a higher prevalence of metabolic syndrome in patients with latent autoimmune diabetes in adults.
NAFLD was associated with higher MetS prevalence in LADA; hypothesis-generating, requires prospective studies before clinical adoption.
Compared with the patients with LADA but without NAFLD, the prevalence of MetS was obviously higher, and had more serious metabolic disorder in the patients with LADA and NAFLD. The presence of NAFLD was an independent factor associated with MetS in the patients with LADA.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2018) studied this question. Non-alcoholic fatty liver disease was independently associated with a higher prevalence of metabolic syndrome and more severe metabolic disorders in patients with latent autoimmune diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: